As GLP-1 frenzy grips India, firms race to build businesses around the weight-loss drug boom Moneycontrol.comSemaglutide generics regain momentum in July — but few brands lead the charge ET PharmaGLP-1 agonist market rebounds in July, reaches Rs 2,215 crore MAT sales: Sheetal Sapale BioSpectrum IndiaQuality in GLP-1 medicines: Why It matters for long-term diabetes care expresshealthcare.inConference on Diabetes organized by HELP foundation tomorrow Get Bengal
As GLP-1 frenzy grips India, firms race to build businesses around the weight-loss drug boom Moneycontrol.comSemaglutide generics regain momentum in July — but few brands lead the charge ET PharmaGLP-1 agonist market rebounds in July, reaches Rs 2,215 crore MAT sales: Sheetal Sapale BioSpectrum IndiaQuality in GLP-1 medicines: Why It matters for long-term diabetes care expresshealthcare.inConference on Diabetes organized by HELP foundation tomorrow Get Bengal
